Search

Bastos, Débora C, Caroline F Ribeiro, Thomas Ahearn, Jéssica Nascimento, Hubert Pakula, John Clohessy, Lorelei Mucci, et al. 2021. “Genetic Ablation of FASN Attenuates the Invasive Potential of Prostate Cancer Driven by Pten Loss.”. The Journal of Pathology 253 (3): 292-303.

Chaudagar, Kiranj Kishor, Natalie Landon-Brace, Aniruddh Solanki, Hanna M Hieromnimon, Emma Hegermiller, Wen Li, Yue Shao, et al. 2021. “Cabozantinib Unlocks Efficient In Vivo Targeted Delivery of Neutrophil-Loaded Nanoparticles into Murine Prostate Tumors.”. Molecular Cancer Therapeutics 20 (2): 438-49.

Nachmani, Daphna, Anne H Bothmer, Silvia Grisendi, Aldo Mele, Dietmar Bothmer, Jonathan D Lee, Emanuele Monteleone, et al. 2019. “Germline NPM1 Mutations Lead to Altered RRNA 2’-O-Methylation and Cause Dyskeratosis Congenita.”. Nature Genetics 51 (10): 1518-29.

Ali, Azhar, Elena Levantini, Jun Ting Teo, Julian Goggi, John G Clohessy, Chan Shuo Wu, Leilei Chen, et al. 2018. “Fatty Acid Synthase Mediates EGFR Palmitoylation in EGFR Mutated Non-Small Cell Lung Cancer.”. EMBO Molecular Medicine 10 (3).

Bezzi, Marco, Nina Seitzer, Tomoki Ishikawa, Markus Reschke, Ming Chen, Guocan Wang, Caitlin Mitchell, et al. 2018. “Diverse Genetic-Driven Immune Landscapes Dictate Tumor Progression through Distinct Mechanisms.”. Nature Medicine 24 (2): 165-75.

Matsumoto, Akinobu, Alessandra Pasut, Masaki Matsumoto, Riu Yamashita, Jacqueline Fung, Emanuele Monteleone, Alan Saghatelian, Keiichi I Nakayama, John G Clohessy, and Pier Paolo Pandolfi. 2017. “MTORC1 and Muscle Regeneration Are Regulated by the LINC00961-Encoded SPAR Polypeptide.”. Nature 541 (7636): 228-32.

Lunardi, Andrea, Caterina Nardella, John G Clohessy, and Pier Paolo Pandolfi. 2014. “Of Model Pets and Cancer Models: An Introduction to Mouse Models of Cancer.”. Cold Spring Harbor Protocols 2014 (1): 17-31.

Nardella, Caterina, Andrea Lunardi, Giuseppe Fedele, John G Clohessy, Andrea Alimonti, Sara C Kozma, George Thomas, Massimo Loda, and Pier Paolo Pandolfi. 2011. “Differential Expression of S6K2 Dictates Tissue-Specific Requirement for S6K1 in Mediating Aberrant MTORC1 Signaling and Tumorigenesis.”. Cancer Research 71 (10): 3669-75.

Clohessy, John G, and Pier Paolo Pandolfi. 2009. “Beta-Tting on P63 As a Metastatic Suppressor.”. Cell 137 (1): 28-30.

Nardella, Caterina, Arkaitz Carracedo, Andrea Alimonti, Robin M Hobbs, John G Clohessy, Zhenbang Chen, Ainara Egia, et al. 2009. “Differential Requirement of MTOR in Postmitotic Tissues and Tumorigenesis.”. Science Signaling 2 (55): ra2.